The GLP-1 Receptor Agonist Liraglutide Improves Autophagy Impairment in the Diabetic Heart

被引：0
|
作者：
Bugyei-Twum, Antoinette [1 ]
Switzer, Jennifer [1 ]
Singh, Krishna K. [1 ]
Connelly, Kim A. [1 ]
机构：
[1] St Michaels Hosp, Toronto, ON, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2017年 / 37卷
关键词：
Autophagy; Diabetes (Type II);
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
368
引用
收藏
页数：1
相关论文
共 50 条
  • [21] GLP-1 receptor agonist liraglutide alleviates kidney injury by regulating nuclear translocation of NRF2 in diabetic nephropathy
    Lin, Tingting
    Zhang, Yuze
    Wei, Qifeng
    Huang, Zugui
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2024, 51 (12)
  • [22] The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
    Secher, Anna
    Jelsing, Jacob
    Baquero, Arian F.
    Hecksher-Sorensen, Jacob
    Cowley, Michael A.
    Dalboge, Louise S.
    Hansen, Gitte
    Grove, Kevin L.
    Pyke, Charles
    Raun, Kirsten
    Schaffer, Lauge
    Tang-Christensen, Mads
    Verma, Saurabh
    Witgen, Brent M.
    Vrang, Niels
    Knudsen, Lotte Bjerre
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10): : 4473 - 4488
  • [23] Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats
    Shohei Yamada
    Jun Tanabe
    Yuji Ogura
    Yoshio Nagai
    Takeshi Sugaya
    Keiichi Ohata
    Yasunori Natsuki
    Daisuke Ichikawa
    Shiika Watanabe
    Kazuho Inoue
    Seiko Hoshino
    Kenjiro Kimura
    Yugo Shibagaki
    Atsuko Kamijo-Ikemori
    Clinical and Experimental Nephrology, 2021, 25 : 365 - 375
  • [24] Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
    Vandemark, Collin
    Nguyen, Jimmy
    Zhao, Zhi-Qing
    MOLECULES, 2023, 28 (03):
  • [25] Monotherapy with GLP-1 receptor agonist, Lixisenatide, significantly improves glycaemic control in type 2 diabetic patients
    Gerich, J. E.
    Fonseca, V. A.
    Alvarado-Ruiz, R.
    Raccah, D.
    Zieleniuk, I.
    Boka, G.
    Miossec, P.
    DIABETOLOGIA, 2010, 53
  • [26] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
    Gallwitz, B.
    DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
  • [27] Liraglutide 3 mg Treatment of Adiposity: GLP-1 Receptor Agonist as new Therapeutic Option
    Aberle, Jens
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (04): : 4 - 10
  • [28] Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats
    Yamada, Shohei
    Tanabe, Jun
    Ogura, Yuji
    Nagai, Yoshio
    Sugaya, Takeshi
    Ohata, Keiichi
    Natsuki, Yasunori
    Ichikawa, Daisuke
    Watanabe, Shiika
    Inoue, Kazuho
    Hoshino, Seiko
    Kimura, Kenjiro
    Shibagaki, Yugo
    Kamijo-Ikemori, Atsuko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (04) : 365 - 375
  • [29] A once-monthly GLP-1 receptor agonist for treatment of diabetic cats
    Schneider, E. L.
    Reid, R.
    Parkes, D. G.
    Lutz, T. A.
    Ashley, G. W.
    Santi, D. V.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2020, 70
  • [30] GLP-1 receptor agonist-induced diabetic ketoacidosis: A case report
    Zhang, Jiaming
    Ma, Ying
    Zu, Qianhe
    Wang, Xiaohui
    Zhang, Yao
    MEDICINE, 2024, 103 (39)
12345